Readers were amazed by our February story about Hebrew University-Hadassah Medical School Prof. David Naor, who’s developing one drug that shows promise in its ability to treat a host of incurable inflammatory diseases such as Crohn’s, ulcerative colitis, rheumatoid arthritis and multiple sclerosis as well as neurodegenerative maladies such as Alzheimer’s disease. If he can raise the money for human trials, his novel peptide could prove to be a game-changer.

Prof. David Naor at Hebrew University-Hadassah Medical School, Jerusalem. Photo by Miriam Alster/FLASH90